Assessments of vaccines for prenatal immunization

Vaccine

Volumn 31, Issue S4, 2013, Pages

  Steinhoff, Mark C ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

Maternal immunization; Pneumococcus; Prenatal vaccines

Indexed keywords

INFLUENZA VACCINE; MATERNAL ANTIBODY; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; TETANUS TOXOID;

CLINICAL TRIAL (TOPIC); DELIVERY; HUMAN; IMMUNIZATION; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; MOTHER FETUS RELATIONSHIP; PASSIVE IMMUNIZATION; PERTUSSIS; PNEUMOCOCCAL INFECTION; PREGNANT WOMAN; PRENATAL PERIOD; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; REVIEW; TETANUS; VACCINATION;

MATERNAL IMMUNIZATION; PNEUMOCOCCUS; PRENATAL VACCINES;

FEMALE; HUMANS; IMMUNIZATION; IMMUNIZATION PROGRAMS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; INFLUENZA VACCINES; INFLUENZA, HUMAN; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PREGNANCY; TETANUS; TETANUS TOXOID; UNITED STATES; WHOOPING COUGH;

EID: 84883041185     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.02.031     Document Type: Review

References (33)

1. Black R.E., Huber D.H., Curlin G.T. Reduction of neonatal tetanus by mass immunization of non-pregnant women: duration of protection provided by one or two doses of aluminium-adsorbed tetanus toxoid. Bull World Health Organ 1980, 58:927-930.
2. Blencowe H., Lawn J., Vandelaer J., Roper M., Cousens S. Tetanus toxoid immunization to reduce mortality from neonatal tetanus. Int J Epidemiol 2010, 39(Suppl. 1):i102-i109.
3. Newell K.W., Duenas Lehmann A., LeBlanc D.R., Garces Osorio N. The use of toxoid for the prevention of tetanus neonatorum. Final report of a double-blind controlled field trial. Bull World Health Organ 1966, 35:863-871.
4. Schofield F.D., Tucker V.M., Westbrook G.R. Neonatal tetanus in New Guinea effect of active immunization in pregnancy. Br Med J 1961, 2:785-789.
5. Source for WHO information regarding maternal and neonatal tetanus elimination project, [accessed 29.11.12]. http://www.who.int/immunization_monitoring/diseases/MNTE_resources/en/index.html.
6. Ortiz J.R., Englund J.A., Neuzil K.M. Influenza vaccine for pregnant women in resource-constrained countries: a review of the evidence to inform policy decisions. Vaccine 2011, 29:4439-4452.
7. Englund J.A., Anderson E.L., Reed G.F., Decker M.D., Edwards K.M., Pichichero M.E., et al. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics 1995, 96:580-584.
8. Enwere G., Biney E., Cheung Y.B., Zaman S.M., Okoko B., Oluwalana C., et al. Epidemiologic and clinical characteristics of community-acquired invasive bacterial infections in children aged 2-29 months in The Gambia. Pediatr Infect Dis J 2006, 25:700-705.
9. Mudhune S., Wamae M. Report on invasive disease and meningitis due to Haemophilus influenzae and Streptococcus pneumonia from the network for surveillance of pneumococcal disease in the East African Region. Clin Infect Dis 2009, 48(Suppl. 2):S147-S152.
10. Traore Y., Tameklo T.A., Njanpop-Lafourcade B.M., Lourd M., Yaro S., Niamba D., et al. Incidence, seasonality, age distribution, and mortality of pneumococcal meningitis in Burkina Faso and Togo. Clin Infect Dis 2009, 48(Suppl. 2):S181-S189.
11. Lehmann D., Pomat W.S., Combs B., Dyke T., Alpers M.P. Maternal immunization with pneumococcal polysaccharide vaccine in the highlands of Papua New Guinea. Vaccine 2002, 20:1837-1845.
12. Obaro S.K., Deubzer H.E., Newman V.O., Adegbola R.A., Greenwood B.M., Henderson D.C. Serotype-specific pneumococcal antibodies in breast milk of Gambian women immunized with a pneumococcal polysaccharide vaccine during pregnancy. Pediatr Infect Dis J 2004, 23:1023-1029.
13. Quiambao B.P., Nohynek H.M., Kayhty H., Ollgren J.P., Gozum L.S., Gepanayao C.P., et al. Immunogenicity and reactogenicity of 23-valent pneumococcal polysaccharide vaccine among pregnant Filipino women and placental transfer of antibodies. Vaccine 2007, 25:4470-4477.
14. Shahid N.S., Steinhoff M.C., Hoque S.S., Begum T., Thompson C., Siber G.R. Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine. Lancet 1995, 346:1252-1257.
15. Holmlund E., Nohynek H., Quiambao B., Ollgren J., Kayhty H. Mother-infant vaccination with pneumococcal polysaccharide vaccine: persistence of maternal antibodies and responses of infants to vaccination. Vaccine 2011, 29:4565-4575.
16. Makris M.C., Polyzos K.A., Mavros M.N., Athanasiou S., Rafailidis P.I., Falagas M.E. Safety of hepatitis B, pneumococcal polysaccharide and meningococcal polysaccharide vaccines in pregnancy: a systematic review. Drug Saf 2012, 35:1-14.
17. Chaithongwongwatthana S., Yamasmit W., Limpongsanurak S., Lumbiganon P., DeSimone J.A., Baxter J.K., et al. Pneumococcal vaccination during pregnancy for preventing infant infection. Cochrane Database Syst Rev 2012, 7:CD004903.
18. Whitney C.G., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., Lynfield R., et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003, 348:1737-1746.
19. Fiore A.E., Uyeki T.M., Broder K., Finelli L., Euler G.L., Singleton J.A., et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010, 59:1-62.
20. Tamma P.D., Steinhoff M.C., Omer S.B. Influenza infection and vaccination in pregnant women. Expert Rev Respir Med 2010, 4:321-328.
21. Poehling K.A., Edwards K.M., Weinberg G.A., Szilagyi P., Staat M.A., Iwane M.K., et al. The underrecognized burden of influenza in young children. N Engl J Med 2006, 355:31-40.
22. Zaman K., Roy E., Arifeen S.E., Rahman M., Raqib R., Wilson E., et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008, 359:1555-1564.
23. Steinhoff M.C., Omer S.B., Roy E., El Arifeen S., Raqib R., Dodd C., et al. Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. Can Med Assoc J 2012, 184:645-653.
24. Steinhoff M.C., Omer S.B. A review of fetal and infant protection associated with antenatal influenza immunization. Am J Obstet Gynecol 2012, 207:S21-S27.
25. Omer S.B., Goodman D., Steinhoff M.C., Rochat R., Klugman K.P., Stoll B.J., et al. Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS Med 2011, 8:e1000441.
26. Who recommends seasonal influenza vaccination to pregnant women as the highest priority, [accessed 29.11.12]. http://www.who.int/immunization/newsroom/newsstory_seasonal_influenza_vaccination_pregnancy/en/index.html.
27. Vaccines against influenza, WHO position paper - November 2012, [accessed 29.11.12]. http://www.who.int/wer/2012/wer8747.pdf.
28. Winter K., Harriman K., Zipprich J., Schechter R., Talarico J., Watt J., et al. California pertussis epidemic, 2010. J Pediatr 2012, 161:1091-1096.
29. Skowronski D.M., Janjua N.Z., Tsafack E.P., Ouakki M., Hoang L., De Serres G. The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization. Clin Infect Dis 2012, 54:318-327.
30. Gall S.A. Prevention of pertussis, tetanus, and diphtheria among pregnant, postpartum women, and infants. Clin Obstet Gynecol 2012, 55:498-509.
31. Newborns to be protected against whooping cough, [accessed 29.11.12]. http://mediacentre.dh.gov.uk/2012/09/28/newborns-to-be-protected-against-whooping-cough/.
32. Centers for Disease C, Prevention Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011, 60:1424-1426.
33. Leuridan E., Hens N., Peeters N., de Witte L., Van der Meeren O., Van Damme P. Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants. Pediatr Infect Dis J 2011, 30:608-610.